Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03703102 · COMPLETED
Trial details
- NCT number
- NCT03703102
- Sponsor
- Kyowa Kirin, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2020-02-06
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.